Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells

Deli Huang; Jenny Tuyet Tran; Alex Olson; Thomas Vollbrecht; Mary Tenuta; Mariia V Guryleva; Roberta P Fuller; Torben Schiffner; Justin R Abadejos; Lauren Couvrette; Tanya R Blane; Karen Saye; Wenjuan Li; Elise Landais; Alicia Gonzalez-Martin; William Schief; Ben Murrell; Dennis R Burton; David Nemazee; James E Voss

doi:10.1038/s41467-020-20304-y

Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells

Nat Commun. 2020 Dec 7;11(1):6360. doi: 10.1038/s41467-020-20304-y.

Authors

Deli Huang¹, Jenny Tuyet Tran¹, Alex Olson¹, Thomas Vollbrecht², Mary Tenuta¹, Mariia V Guryleva^{3

4}, Roberta P Fuller^{1

5

6}, Torben Schiffner^{1

5

6}, Justin R Abadejos¹, Lauren Couvrette^{1

7}, Tanya R Blane¹, Karen Saye^{1

5

6}, Wenjuan Li¹, Elise Landais^{1

5}, Alicia Gonzalez-Martin⁸, William Schief^{1

5

6

9}, Ben Murrell¹⁰, Dennis R Burton^{11

12

13

14}, David Nemazee¹⁵, James E Voss¹⁶

Affiliations

¹ Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
² Department of Medicine, The University of California San Diego, La Jolla, CA, USA.
³ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
⁴ Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow, Russia.
⁵ Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.
⁶ IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.
⁷ Faculty of Science, University of Ottawa, Ottawa, Canada.
⁸ Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain.
⁹ Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA.
¹⁰ Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se.
¹¹ Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
¹² Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
¹³ IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.
¹⁴ Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA. burton@scripps.edu.
¹⁵ Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu.
¹⁶ Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.

Abstract

A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20304-y.

Publication types

Published Erratum